Newsfiscal.ai
Rallybio Announces Merger with Avenzo Therapeutics and Special Cash Distribution
· Published
Article summary
Rallybio Corporation has entered into a merger agreement with Avenzo Therapeutics, supported by $215 million in investor funding, and announced a planned special cash distribution for stockholders.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…